Articles tagged "Outcome"

2020 American Transplant Congress
Prevalence and Predictors of Sensory Polyneuropathic Signs and Symptoms in Renal Transplant Recipients
S. Nolte¹, J. Hofman¹, A. Gomes-Neto¹, B. de Greef², J. Elting¹, M. Eisenga¹, M. van Londen¹, S. Bakker¹, I. Nolte¹, C. Faber², J. Sanders¹, D. Touw¹, I. Lesman-Leegte¹, S. Berger¹, G. Drost¹
¹University Medical Center Groningen, Groningen, Netherlands, ²Maastricht University Medical Center, Maastricht, Netherlands
*Purpose: Sensory polyneuropathy is a common finding in renal transplant recipients (RTR). Patients with end stage renal disease are at a high risk to develop…
2020 American Transplant Congress
Discontinuation Rates in Multicenter Trials – Are They Driven by Attitudes or Facts?
B. Nashan¹, F. Braun², D. Dragun³, I. A. Hauser³, P. Schemmer², H. J. Schlitt², C. Sommerer³, B. Suwelack³, C. Schiedel⁴, I. Kroeger⁴, F. Thaiss³
¹Athena and Hephaistos, Study Group, Germany, ²Hephaistos, Study Group, Germany, ³Athena, Study Group, Germany, ⁴Novartis Pharma GmbH, Nürnberg, Germany
*Purpose: The ATHENA [NCT01843348] and Hephaistos [NCT01551212] trials were designed to compare everolimus [EVR] in combination with reduced tacrolimus [rTAC] or reduced cyclosporine A [rCyA]…
2020 American Transplant Congress
Alcohol Relapse after Liver Transplant for Alcohol-Related Cirrhosis: A Longitudinal Assessment of Risk Factors for Relapse and Long-Term Survival
B. Rice, N. Mehta, J. L. Dodge, J. D. Grab, C. Sherman
University of California San Francisco, San Francisco, CA
*Purpose: Relapse to alcohol after liver transplant (LT) is common but likely underreported in patients with alcohol-related cirrhosis (AC). The aim of this study was…
2020 American Transplant Congress
ESRD Risk Prediction for Black vs. White Related Living Kidney Donors
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, L. Cartwright¹, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²Chief Medical Officer, UNOS, Richmond, VA
*Purpose: We studied 25-year risk of post-donation ESRD in black (n=10,214) and white (n=45,700) first-degree related living kidney donors (RLKDs) who donated in the US…
2020 American Transplant Congress
Outreach as a Way to Improve Access to Kidney Transplants: A Model to Align with Future of Kidney Disease Care
A. Govil¹, P. Gudsoorkar¹, C. Siemer², C. King², T. Diwan¹, E. Woodle¹, S. Shah¹, C. V. Thakar¹
¹Univ of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH
*Purpose: In 2018, there were more than 100,000 patients wait-listed for kidney transplant whereas only around 21,000 patients received a kidney transplant. Increasing access to…
2020 American Transplant Congress
Comparison of Metabolic Outcomes after Pancreas Transplantation between DBD (Donors after Brainstem Death) and DCD (Donors after Circulatory Death) Grafts
J. Gopal, A. McLean, J. Crane, P. Herbert, F. Dor, M. Reddy, D. Taube, V. Papalois, A. Muthusamy
Imperial College Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
*Purpose: DCD pancreas transplantation has become common with equivalent graft survival as that of DBD grafts, but are the metabolic outcomes similar? Given the lack…
2020 American Transplant Congress
Risk Factors and Treatment of Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation
G. Chen, C. Wang, Z. Wu, X. Liu, Q. Li, L. Chen
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
*Purpose: Recurrent focal segmental glomerulosclerosis(FSGS) is common after kidney transplantation . We conducted a retrospective cohort study with the aim to investigating the risk factors…
2020 American Transplant Congress
Management of Pancreatic Cancer after Liver Transplantation: A 27-Year Single-Center Experience
I. A. Ziogas, M. A. Rauf, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. P. Alexopoulos
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The occurrence of de novo cancer after liver transplant (LT) is a leading cause of post-LT mortality and can be partially attributed to the…
2020 American Transplant Congress
Livers from Donation after Cardiac Death (DCD) Offer – Accept or Decline?
T. Ishaque, M. G. Bowring, J. D. Motter, Y. Yu, S. Yu, A. B. Kernodle, J. G. Wang, S. Getsin, D. L. Segev, A. B. Massie
Johns Hopkins University, Baltimore, MD
*Purpose: Given the shortage of deceased-donor livers, donation after cardiac death (DCD) provides an opportunity to expand the donor pool. Due to concern over the…
2020 American Transplant Congress
Can Biliary Internal Stents Reduce Biliary Complications in Adult Liver Transplantation?
Y. Kwon¹, Y. S. Genyk¹, Y. Yoon²
¹Division of Hepatobiliary, Pancreas, and Abdominal Organ Transplant, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, ²Division of Hepatobiliary, Pancreas, and Abdominal Organ Transplant, Department of Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of
*Purpose: Biliary complications remain a consistent cause of morbidity and mortality in liver transplant (LT) recipients and there is controversy as to whether the use…